ir.editasmedicine.com ir.editasmedicine.com

ir.editasmedicine.com

Editas Medicine

Editas Medicine

http://ir.editasmedicine.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.EDITASMEDICINE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 10 reviews
5 star
6
4 star
1
3 star
2
2 star
0
1 star
1

Hey there! Start your review of ir.editasmedicine.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.7 seconds

FAVICON PREVIEW

  • ir.editasmedicine.com

    16x16

CONTACTS AT IR.EDITASMEDICINE.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Editas Medicine | ir.editasmedicine.com Reviews
<META>
DESCRIPTION
Editas Medicine
<META>
KEYWORDS
1 toggle navigation
2 company overview
3 our culture
4 our team
5 what is crispr
6 genome editing
7 our programs
8 areas of research
9 our pipeline
10 presentations and publications
CONTENT
Page content here
KEYWORDS ON
PAGE
toggle navigation,company overview,our culture,our team,what is crispr,genome editing,our programs,areas of research,our pipeline,presentations and publications,community,careers at editas,investors and media,more news,core values,testimonials,join editas
SERVER
Apache/2.2.22
POWERED BY
PHP/5.5.35
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Editas Medicine | ir.editasmedicine.com Reviews

https://ir.editasmedicine.com

Editas Medicine

INTERNAL PAGES

ir.editasmedicine.com ir.editasmedicine.com
1

Our Programs

http://www.ir.editasmedicine.com/our-programs

The DNA of Editas. Be a Part of the Team. LATEST NEWS - March 07, 2017. Editas Medicine Announces Fourth Quarter and…. We are working to translate the promise of genome editing into a broad class of genomic medicine that have the potential to transform lives. We have focused our efforts on diseases for which there are currently few or no available treatments because we want to maximize the impact of our technology for those who need it most. And our areas of focus. That might be useful. JM Heath, A. ...

2

One Team, Many Voices, Our History

http://www.ir.editasmedicine.com/our-team

The DNA of Editas. Be a Part of the Team. LATEST NEWS - March 07, 2017. Editas Medicine Announces Fourth Quarter and…. One Team. Many Voices. In November 2013, Editas Medicine secured a $43 million Series A financing led by Flagship Ventures, Polaris Partners and Third Rock Ventures, with participation from the Partners Innovation Fund, and assembled a strong leadership team and board of directors. Exceptional People and Culture. The lifeblood of our company is our exceptional people and culture. Kevin h...

3

CRISPR | Genome Editing, DNA Repair

http://www.ir.editasmedicine.com/crispr

The DNA of Editas. Be a Part of the Team. LATEST NEWS - March 07, 2017. Editas Medicine Announces Fourth Quarter and…. CRISPR is a dynamic, versatile tool that allows us to target nearly any genomic location and potentially repair broken genes. But what exactly is CRISPR? How does it work? CRISPR technology uses a protein-RNA complex composed of either the protein Cas9 or Cpf1, each of which binds to a guide RNA (gRNA) molecule that has been designed to recognize a particular DNA sequence. The second mec...

4

Community

http://www.ir.editasmedicine.com/community

The DNA of Editas. Be a Part of the Team. LATEST NEWS - March 07, 2017. Editas Medicine Announces Fourth Quarter and…. At Editas Medicine, our values are part of our DNA. We are one community. But with many voices. Our employees are resilient. Embracing risks and making tough decisions. At Editas Medicine, our values. Are part of our DNA. We are one community. But with many voices. By thinking bold and big. They are rigorous about our science. Jonathan McNeill, M.D. Manager, Business Development. What ma...

5

Genome Editing, Genome Modification, Gene Therapy

http://www.ir.editasmedicine.com/genome-editing

The DNA of Editas. Be a Part of the Team. LATEST NEWS - March 07, 2017. Editas Medicine Announces Fourth Quarter and…. Our DNA is at the root of each of us that unique combination of genes that makes us all individuals. Major investments in the human genome project and the subsequent development of low-cost and rapid DNA sequencing and informatics tools have revolutionized the understanding of genetically defined diseases and paved the way for advancing the field of genomic medicine. There are several te...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

editasmedicine.com editasmedicine.com

Editas

http://editasmedicine.com/index.php

Unlocking the Promise of Genome Editing. To Deliver Life-Changing Medicines. Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level. August 22, 2016. Editas Medicine Names Charles Albright as Chief Scientific Officer.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

ir.edag.com ir.edag.com

EDAG - Investor Relations

Willkommen auf der Investor Relations Website der EDAG Engineering Group AG. Wir sind einer der weltweit führenden, unabhängigen Ingenieursdienstleister für die internationale Automobilindustrie. Seit 45 Jahren begeistern wir unsere Kunden durch Spitzenleistungen und arbeiten für ihren nachhaltigen technologischen Vorteil. Hier finden Sie alle wichtigen Informationen rund um die EDAG-Aktie. Ihr Kontakt zu EDAG:. EDAG Engineering Group AG. Tel: 41 (0)71 544 33 - 11. Fax: 41 (0)71 544 33 - 10.

ir.edaily.co.kr ir.edaily.co.kr

¢ÆÁ¾ÇÕ °æÁ¦Á¤º¸ ¹Ìµð¾î - À̵¥Àϸ®¢Æ

º ÀýÀº Ö 'ºí µºí µ'ÇÏ é È µÇ ª. º Àº ºûÀ à  ٠ æÀÌ Ù. ºûÀ ÅëÇØ îµÒÀ ÀÌ Ü ö ÀÖ Ù. ªç µéÃç ÀϺ  ì ÎÁ ÀÇ â Ä ÀÎ µéÀ ÀÛ. OCI(ÁÖ) (Á Á ) áÀç Á Ç âÁØ µ . ÇÏ(ÁÖ) Ü â ÀÔ ÝÁõ áÁ. ÇÑÈ ÕÇغ Çè(ÁÖ) â íÈ (IR) . ÁÖ)ÇÑ óÈ µù º ÁöÁÖÈ çÀÇ ÀÚÈ ç . ÁÖ)LG áÀç Á Ç âÁØ µ (ÀáÁ ). ÇØ çÇÏ Â º º ø À Ï Ù. Http:/ www.stx.co.kr/. STX, 9.6 ï ø Ô ð À óÁõÀÚ.Ã Ç Ü . STX(011810)  Á 3ÀÚ èÁ æ ÄÀ Î 9 ï6117 ø Ô ð À óÁõÀÚ áÁ Çß Ù í 30ÀÏ ø ÃÇß Ù. à ÇÀÚ ëóÀ ÎÇÑ ÃâÀÚÀüÈ æ. STX, 99 ï ø Ô ð ÝÀü ë áÁ. STXÁ ÇØ ç À̺ ð ÅÀÓ ëÇ ÀÌç ÃëÀÓ. ÁÖÁøÇü ÇÑ...

ir.edgewater.com ir.edgewater.com

Overview | Edgewater Technology

Skip to main navigation. Turn on more accessible mode. Turn off more accessible mode. Skip to main content. Edgewater is a leading strategic consulting firm that focuses on. Helping companies drive transformational change. The information within this website has been tailored to allow you to review Edgewater Technology’s performance and results. From this site, you have the ability to read our latest press releases. Conduct stock performance analysis using our stock charts. For materials, and much more.

ir.edisoninvestor.com ir.edisoninvestor.com

Edison International

Edison International, through its subsidiaries, is a generator and distributor of electric power and an investor in infrastructure and energy assets, including renewable energy. Headquartered in Rosemead, California, Edison International is the parent company of Southern California Edison a regulated electric utility and Edison Mission Group, a competitive power generation business. Edison International's vision, Leading the Way in Electricity. Southern California Edison (SCE). Edison Mission Group (EMG).

ir.edita.com.eg ir.edita.com.eg

Home - Edita IR

Edita food industries s.a.e. HEALTHY, SAFETY and ENVIRONMENT. BOARD and SHAREHOLDERS ACTIONS. SHARE and CORPORATE INFORMATION. SHARE and CORPORATE INFORMATION. Watch Edita's Corporate Campaign Ad. Last Trade 12/01/2017 02:25 PM. Data delayed 15-20 min. Edita shares also trade on the LSE as GDRs under the symbol EFID. Key product segments across 16 MENA countries. Tons produced annually at our 4 state-of-the-art facilities. Distribution centers and a fleet of 544 distribution vehicles. 10 November, 2016.

ir.editasmedicine.com ir.editasmedicine.com

Editas Medicine

The DNA of Editas. Be a Part of the Team. LATEST NEWS - January 09, 2017. Editas Medicine Reports on Recent Progress…. The DNA of Editas. Be A Part of the Team. The DNA of Editas. Be A Part of the Team. The DNA of Editas. This is the time. There are a few times in our lives when science astonishes us, when we are suddenly able to do something that seemed like science fiction just the day before. This is one of those moments. What if you could repair broken genes? We’re making CRISPR medicines a reality.

ir.edu.mx ir.edu.mx

La Salle - Instituto Regiomontano

ir.edu.ua ir.edu.ua

Институт Рекламы

Початок прийому документів на. Теми творчого конкурсу для напрямку. 171;Реклама та зв’язки з громадськістю. Орієнтовна тематика творчого конкурсу. Інститут реклами перша сходинка на шляху вашого успіху! Вступаючи до нас, Ви можете бути впевнені у високому рівні професійної компетентності викладацького складу та гідній якості освітніх програм. Випускники Інституту це наша гордість. Вони знаходять себе в різних областях економіки, дизайну, журналістики та радують своїх клієнтів гідними проектами. Ми прагне...

ir.educ.utm.my ir.educ.utm.my

Welcome to Faculty of Education Institutional Repository - Faculty of Education Institutional Repository

Welcome to Faculty of Education Institutional Repository. View items added to the repository in the past week. Search the repository using a full range of fields. Use the search field at the top of the page for a quick search. Browse the items in the repository by subject. More information about this site. Policy for use of material in this repository. Faculty of Education Institutional Repository supports. With a base URL of. Http:/ ir.educ.utm.my/cgi/oai2.

ir.edutime.net ir.edutime.net

鐖卞皵鍏扮暀瀛︼紝鐖卞皵鍏板ぇ瀛︼紝鐖卞皵鍏伴櫌鏍★紝鐖卞皵鍏板鏍★紝鐖卞皵鍏板ぇ瀛︽帓鍚嶏紝鐖卞皵鍏版墦宸ワ紝鐖卞皵鍏扮暀瀛﹀瀛﹂噾

鐖卞皵鍏伴 鍗庝娇棣嗙 璇佸畼鎸囩偣鐣欏 鈥滅敵绛锯? 鐣欏 鐖卞皵鍏帮細琛i 浣忚 浠d环鏄傝吹. A 銆 璧寸埍鐣欏 鍏ュ 瑕佹眰. 鐖卞皵鍏扮暀瀛 瀛 噾鍙婂 鏍 帓鍚? 鍜ㄨ 閭 欢锛歛sse2@chiway.com.cn. Br (鏈夌殑瀛 牎瑕佹眰澶у 褰曞彇閫? Br 鐭ヤ功鎴栧畬鎴愬ぇ涓 璇剧 ). 鏈 姣曚笟鎸佹湁瀛 瀛 綅. 璧寸埍鐣欏 鍓嶆惡甯 鏉庨 鐭? 璧寸埍鐣欏 琛屽墠蹇呭 鐗 搧鎸囧崡. 鑻辫 瀛 牎绠 悊濮斿憳浼? A 鐖卞皵鍏颁腑澶 粺璁 眬. 閲戣瀺 / 浼氳 涓撲笟. 閰掑簵 / 鏃呮父 涓撲笟. 35娆у厓銆傚 鐢熷湪鐖卞皵鍏板緢瀹规槗鎵惧埌鍚堥 傝嚜宸辩殑鍕ゅ伐淇 鐨勬満浼氥? 2銆佺暀瀛 埍灏斿叞涓 瀹氳 鑰冮泤鎬濆悧锛? 闆呮 濄 佹墭绂忕瓑鑻辫 娴嬭瘯鏄 ぇ瀛 綍鍙栧拰绛捐瘉瀹 牳鐨勯噸瑕佸弬鑰冩潯浠讹紝寤鸿 瀛 敓鍙傚姞鑰冭瘯銆傚皯鏁板ぇ瀛 彲浠ユ彁渚涜嫳鏂囧叆瀛 祴璇曘? A href="ask.aspx" 鍥藉唴澶т笓姣曚笟,鑳藉惁鍦ㄧ埍灏斿叞璇讳笓鍗囨湰璇剧 锛熷彲浠ワ紝鍓嶆彁鏄 户缁 鐩稿叧涓撲笟锛岄 氬父鍐嶈 1鑷?

ir.edwards.com ir.edwards.com

Edwards Lifesciences Corporation - Investor Relations

Transcatheter Aortic Valve Replacement (TAVR). Other: General Surgery and Balloon Atrioseptostomy. Minimal Incision Valve Surgery. Stock Info and Tools. UNITED STATES - ENGLISH. Brazil - Português. COSTA RICA - Español. China - ä æ ç ä. United Kingdom - English. Europe - Español. Europe - Français. Japan - æ æœ èªž. 35th Annual J.P. Morgan Healthcare Conference. January 9, 2017 - 8:00 AM PST. Jan 11, 2017. Delayed 20 min., by eSignal. Click here to view all recent news releases. Feb 1, 2017 at 5:00 PM ET.